<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35840463</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8171</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The American journal of emergency medicine</Title><ISOAbbreviation>Am J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 diabetes in the context of long COVID.</ArticleTitle><Pagination><StartPage>208</StartPage><EndPage>209</EndPage><MedlinePgn>208-209</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajem.2022.07.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-6757(22)00450-8</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jolobe</LastName><ForeName>Oscar M P</ForeName><Initials>OMP</Initials><AffiliationInfo><Affiliation>British Medical Association, BMA House, Tavistock Square, London WC1H 9JP, United Kingdom. Electronic address: oscarjolobe@yahoo.co.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Emerg Med</MedlineTA><NlmUniqueID>8309942</NlmUniqueID><ISSNLinking>0735-6757</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of Competing Interest I have no conflict of interest or funding with regard to the manuscript with the above title.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>22</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35840463</ArticleId><ArticleId IdType="pmc">PMC9264805</ArticleId><ArticleId IdType="doi">10.1016/j.ajem.2022.07.015</ArticleId><ArticleId IdType="pii">S0735-6757(22)00450-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Szarpak L., Pruc M., Najeeb F., Jaguszewski M.J. Post-Covid-19 and the pancreas. Am J Emerg Med. 2022 doi: 10.1016/j.ajem.2022.04.023. Article in Press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2022.04.023</ArticleId><ArticleId IdType="pmc">PMC9040502</ArticleId><ArticleId IdType="pubmed">35644682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunal S., Maden M., Tarke C., Gautam D.K., Kinkar J.S., Gupta K., et al. Emerging spectrum of post-COVID-19 syndrome. Postgrad Med J. 2021 doi: 10.1136/postgradmedj2020-139585. First published on line 08 December.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj2020-139585</ArticleId><ArticleId IdType="pubmed">34880080</ArticleId></ArticleIdList></Reference><Reference><Citation>Seewaldt S., Thomas H.E., Ejrnaes M., Christen U., Wolfe T. Rodrigo E et al, virus-induced autoimmune diabetes, Most Beta cells die through inflammatory cytokines and not perforin from autoreactive(anti-viral) cytotoxic T-lymphocytes. Diabetes. 2000;49:1801&#x2013;1809.</Citation><ArticleIdList><ArticleId IdType="pubmed">11078446</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher G.R., Brehm M.A., Finberg R.W., Barton B.A., Shultz L.D., Greiner D.L., et al. Viral infection of engrafted human islets leads to diabetes. Diabetes. 2015;64:1358&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375078</ArticleId><ArticleId IdType="pubmed">25392246</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L., Edwin B., Buanes T., Frisk G., Skog O. Anagandula M et al, detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2015;64:1682&#x2013;1687.</Citation><ArticleIdList><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller J.A., GroB R., Conzelmann C., Kruger J., Merle U., Steinhart J. Weil T et al, SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021;3:149&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">33536639</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett C.E., Koyama A.K., Alvarez P., Chow W., Lundeen E.A., Perrine C.G., et al. Risk of newly diagnosed diabetes &gt; 30 days after SARS-CoV-2 infection among persons aged &lt; 18 years -United States, March 1, 2020-June 28, 2021. Morb Mortal Wkly Rep. 2022;71:59&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757617</ArticleId><ArticleId IdType="pubmed">35025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J.J.L. Persistent SARS-2 infections contribute to long COVID-19. Med Hypotheses. 2021;149 doi: 10.1016/j.medhy.2021.110538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medhy.2021.110538</ArticleId><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S. Tokuyama M et al, evolution of antibody immunity to SARS-co-V2. Nature. 2021;591:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Alter G., Walt D.R. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. medRxiv. 2022 doi: 10.1101/2022.06.14.22276401. preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.14.22276401</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., et al. Immunological dysfunction persists for 8 months following initial mild to moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppieters K.T., Wiberg A., von Herrath M.G. Viral infections and molecular mimicry in Type 1 diabetes. Acta Pathol Microbiol Immunol Scand A. 2012;120:941&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5774991</ArticleId><ArticleId IdType="pubmed">23051179</ArticleId></ArticleIdList></Reference><Reference><Citation>De Las Penas C., Martin-Guerrero J.D., Pellicer-Valero O.J., Navaro-Pardo E., Gomez-Mayordomo V., Cuadrado M.L., et al. Female sex is a risk factor associated with long-term post-covid related-symptoms but NOT with COVID-19 symptoms: the long-COVID-EXP-CM multicenter study, journal of. Clin Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>